Strategic Plan

The FY25-29 Strategic Plan enables the National Psoriasis Foundation to address the hurdles faced in today's health care landscape, as we accelerate our drive to find a cure. The strategic plan is built around two goals of equal importance: 

Goal 1: Cure Psoriatic Disease

NPF is steadfast in our commitment to cure psoriatic disease. To realize this, we will invest in passing the milestones necessary to reach a world free from psoriatic disease and its burdens. We will also support the expansion of the psoriatic disease research infrastructure and grow the clinical workforce across disciplines.

Goal 2: Optimize Health for Everyone Living with Psoriatic Disease, Now

NPF is working to ensure access to life-changing therapies. We have begun bridging better connections between people with psoriatic disease and qualified health care providers, while continuing to pay special attention to traditionally underserved populations.

Fiscal Years 2025-29 Strategic Plan

This strategic plan is only possible with the participation and generosity of the supporters, donors, and volunteers who have led the way at NPF since 1967. We look forward to engaging with you and your fellow community members on this new plan.

NPF is forever appreciative of your involvement in the mission to cure this chronic disease. 

Read the strategic plan
NPF volunteer Matt Kiselica speaks at a podium at an NPF event.

Support the Mission

Invest in NPF's work in research, advocacy, and education.

Give today
A group of people at a Take ACTION for Psoriatic Disease event.

Join the Movement

Volunteering is a hands-on way to improve the lives of those with psoriatic disease.

Sign up
Researcher Nehal Mehta smiles while wearing his white coat.

Partner with NPF

Become an NPF Professional Member and commit to improving care and treatment.

Start your membership

Moving Forward Together

NPF developed its strategic plan with input from all stakeholders in the psoriatic disease and health advocacy communities. Key contributions were made by expert dermatologists, rheumatologists, and researchers, in addition to medical professionals, advocacy organizations and community groups, and industry partners.

Most importantly, the plan is informed by those who live with psoriatic disease, including individuals from traditionally underserved populations. This approach was used to put people with the disease – and those who know how best to treat it – at the forefront of the decision-making process as the plan evolved.

Thank you for your continued partnership as we improve access to care and continue provide exemplary support to the 8 million people in the U.S. and 125 million worldwide who are living with psoriatic disease. 

Successes in Recent Years

Because of you, NPF:

  • Launched and funded the PsA Diagnostic Test Grant and Psoriasis Prevention Initiative, leading to groundbreaking advancements. 
  • Included psoriatic disease in the Accelerating Medicines Partnership for immune-mediated diseases, unlocking new collaborative research opportunities and funding. 
  • Helped 36 states pass step therapy or copay accumulator legislation, creating better access to prescribed care. 
  • Advocated, a Medicare out-of-pocket cap and smoothing mechanism goes into effect in 2025. 
  • Updated the guidelines for the treatment of psoriatic disease alongside the American Academy of Dermatology and the American College of Rheumatology. 
  • Delivered the latest information and resources to over 4 million visitors per year at psoriasis.org. 

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.